CMS Suggests Noncoverage of Boston Sci Wingspan, Except In Clinical Trials

Boston Scientific's Wingspan intracranial stent would not be covered by Medicare except during FDA-cleared clinical trials, according to a 1CMS proposed rule issued Aug. 9

More from Archive

More from Medtech Insight